VET

CTCP Thuốc thú y Trung ương Navetco · UPCOM

14,000 Latest close · 02 Jul 2026 P/E 12.5x P/B 0.7x

Showing improvement · Net margin 5.94%, +16.26pp YoY

On a TTM 2026Q1 basis, VET posted a sharp profit increase versus the same period, suggesting a clear improvement from a low base — this marks a reversal from the difficult phase before. However, profit is significantly supported by non-core sources and operating cash flow is not yet positive — the improvement signal needs more time to confirm.

Revenue TTM

VND 301bn

−21.3%

Net Margin

5.94%

+16.3pp year on year

ROE

5.8%

TTM

View Full Financial Analysis